Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/23/2003US20030198727 Oil/fat composition
10/23/2003US20030198726 Matrix-forming composition containing pectin
10/23/2003US20030198695 Herbo-mineral composition
10/23/2003US20030198692 Red algae extract; human, veterinary medicine; mixture of cell permeability agent and microbiocide
10/23/2003US20030198691 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
10/23/2003US20030198689 Nontoxic aqueous solution; electrolysis; bactericide, viricide
10/23/2003US20030198683 Controlled release oral dosage form
10/23/2003US20030198680 Solid, free-flowing powder; solid hydrophobic nanostructure; moisture trigger release
10/23/2003US20030198679 Flocculated pharmaceutical suspensions and methods for actives
10/23/2003US20030198678 Polynucleotide immobilized with block polyether polymer; antibodies against genetic disorders
10/23/2003US20030198676 Sustained-release preparation for AII antagonist, production and use thereof
10/23/2003US20030198675 Method of providing sustained analgesia with buprenorphine
10/23/2003US20030198674 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
10/23/2003US20030198672 Levothyroxine mixed with cellulose; immediate release solid dosage form; dietetics; glandular disorders; cardiovascular disorders
10/23/2003US20030198671 Levothyroxine mixed with cellulose; immediate release solid dosage form; dietetics; glandular disorders; cardiovascular disorders
10/23/2003US20030198670 Albuterol sulfate core and overcoatings
10/23/2003US20030198668 Levothyroxine pharmaceutical compositions, methods of making and methods of administration
10/23/2003US20030198667 Methods of producing dispersible pharmaceutical compositions
10/23/2003US20030198662 Central nervous system disorders; psychological disorders
10/23/2003US20030198661 Veterinary medicine; stress resistance; administering vitamin E and vitamin C; feeds
10/23/2003US20030198656 N-acetylamino acids, related N-acetyl compounds and their topical use
10/23/2003US20030198652 Multi component controlled release system for anhydrous cosmetic compositons
10/23/2003US20030198643 Adjuvant enhanced immunotherapy
10/23/2003US20030198642 Vaccine vehicle; induce immunology response; anticancer agents
10/23/2003US20030198640 Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
10/23/2003US20030198637 Antiproliferative agent; induction apoptosis; antitumor agents
10/23/2003US20030198619 Mixture containing permeability intensifier; in situ gelation using nonionic surfactant
10/23/2003US20030198616 Moisturizing skin gel and method
10/23/2003US20030198614 Hair growers
10/23/2003US20030198611 Method of treating onychomycosis with urea and an antioxidant
10/23/2003US20030198610 Topical agent for dermatological use
10/23/2003US20030198609 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
10/23/2003US20030198608 Ultraviolet absorbent, photostabilizer, ultraviolet ray-absorbing composition, photostabilized composition and external prepraration for skin
10/23/2003US20030198601 Dry powder drug; aerosol administering
10/23/2003US20030198600 Mixture of drug, propellant and cosolvent; breathing device
10/23/2003US20030196968 Industrial water treatment; papermaking; nitrogen-containing compounds: 1-(3-chloroallyl)-3,5,7-triaza-1-azonia-adamantane chloride, dodcylguanadine hydrochloride; aldehydes: glutaraldehyde, formaldehyde; klebsiella; pseudomonas
10/23/2003US20030196274 Counteracting bioprosthetic calcification
10/23/2003EP1494675A2 Inhibitors of akt activity
10/23/2003DE20310493U1 Micronutrient combination product for dietetic treatment of inflammatory-rheumatic diseases and osteoporosis, containing specific amounts of several vitamins, minerals, trace elements and antioxidants
10/23/2003DE19983836C1 Verfahren zur Herstellung von Citalopram, 4-[1-(4- Fluorphenyl)-methanoyl]-benzonitril-Derivate und Verfahren zu deren Herstellung und deren Verwendung A process for the preparation of citalopram, 4- [1- (4-fluorophenyl) -methanoyl] -benzonitrile derivatives and process for their preparation and their use
10/23/2003DE10218312C1 New bis-(amino-hydrocarbyloxy or N-containing heterocyclyloxy)-silicon compounds, useful as anticancer agents
10/23/2003CA2485679A1 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2482940A1 Hair growth tonic
10/23/2003CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003CA2482877A1 Parasite control in animals
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482703A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
10/23/2003CA2482669A1 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
10/23/2003CA2482646A1 Method of stabilizing bupropion hydrochloride tablets
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482544A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003CA2482391A1 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2482313A1 Heterocyclic compounds
10/23/2003CA2482312A1 Thienyl compounds
10/23/2003CA2482263A1 Therapeutic dry powder preparation
10/23/2003CA2482230A1 Polyphosphonate derivatives for toothpaste compositions
10/23/2003CA2482216A1 Patch and process for producing the same
10/23/2003CA2482195A1 Farnesoid x-activated receptor agonists
10/23/2003CA2481855A1 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003CA2481705A1 Hydrothermically processed compositions containing phytosterols
10/23/2003CA2481702A1 Urea compositions
10/23/2003CA2481683A1 Ansamycin formulations and methods for producing and using same
10/23/2003CA2481677A1 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/23/2003CA2481669A1 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003CA2481667A1 Sustained release pharmaceutical prepartations and methods for producing the same
10/23/2003CA2481603A1 Method and composition for improving fertility health in female and male animals and humans
10/23/2003CA2481595A1 Solid dispersion composition
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481391A1 Preventives/remedies for hotflash
10/23/2003CA2481387A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003CA2481384A1 Aqueous dispersible steryl ester compositions
10/23/2003CA2481372A1 Method to inhibit cell growth using oligonucleotides
10/23/2003CA2481370A1 Process for preparing tannate liquid and semi-solid dosage forms
10/23/2003CA2481344A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003CA2481320A1 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003CA2481313A1 Bicyclic amides
10/23/2003CA2481306A1 Metastasis modulating activity of highly sulfated oligosaccharides
10/23/2003CA2481272A1 The use of devazepide as analgesic agent
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2481239A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003CA2481187A1 Formoterol and ciclesonide aerosol formulations
10/23/2003CA2481184A1 Medicament for preventing and/or treating chronic rejection
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2481092A1 Low dose liquid entecavir formulations and use
10/23/2003CA2481091A1 Sustained release metoprolol formulations
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2480879A1 Tyrosine kinase inhibitors
10/23/2003CA2480860A1 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480814A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003CA2480764A1 Novel polymorphs and pseudopolymorphs of resedronate sodium
1 ... 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 ... 7860